Holiday travel, 'Wicked: For Good' debut and more: Morning Squawk

As the trading day begins, investors are reflecting on a tumultuous week in the stock market, driven by ongoing concerns surrounding the artificial intelligence sector and broader economic indicators. Fortunately, stocks made a slight recovery on Friday, fueled by optimism regarding a potential interest rate cut. In a significant legal development, a recent filing alleges that Meta ceased internal research which suggested that users who stopped using Facebook reported lower levels of depression and anxiety. The study, initiated in 2019, aimed to explore the effects of Meta's platforms on various social dynamics, including polarization and well-being. This allegation forms part of a larger legal battle involving multiple social media companies, with Meta's spokesperson contesting the claims as misleading and based on selective information. In the biotech sector, shares of Novo Nordisk plummeted over 10% following the announcement that their Alzheimer's drug trial failed to meet its primary endpoint. Analysts had anticipated a challenging outcome for the trial assessing the drug semaglutide's efficacy in slowing cognitive decline, despite previous studies indicating positive results on Alzheimer's biomarkers. Novo’s chief scientific officer emphasized the company's commitment to investigating semaglutide's potential, despite the slim chances of success. Looking ahead to the holiday season, U.S. airlines are preparing for an unprecedented Thanksgiving travel period. American Airlines' operations chief highlighted the high stakes involved, with estimates suggesting that over 31 million passengers will be traveling from November 21 to December 1. This surge in travel comes on the heels of a recent government shutdown that impacted about 6 million flyers. To incentivize air traffic controllers and technicians who maintained perfect attendance during the shutdown, bonuses of $10,000 will be awarded. Meanwhile, Universal's latest release, "Wicked: For Good," has made waves at the box office, amassing approximately $150 million in domestic ticket sales during its opening weekend. This impressive figure marks it as the second-largest opening for a 2025 film release and the highest debut for a Broadway adaptation, surpassing the first installment's earnings from last year. With around 10 million tickets sold, industry experts predict that this film could significantly influence the Thanksgiving box office landscape. As the week progresses, stakeholders are encouraged to stay updated on the latest developments. CNBC Pro subscribers can access a comprehensive calendar and additional insights for the week ahead.